Rice Hall James & Associates LLC grew its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 7.7% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 185,780 shares of the health services provider's stock after buying an additional 13,234 shares during the period. Rice Hall James & Associates LLC owned approximately 0.33% of Maximus worth $12,668,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in MMS. UMB Bank n.a. boosted its holdings in Maximus by 70.2% during the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock worth $41,000 after buying an additional 250 shares during the last quarter. GAMMA Investing LLC boosted its holdings in Maximus by 67.1% during the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after buying an additional 294 shares during the last quarter. Farther Finance Advisors LLC boosted its holdings in Maximus by 109.2% during the fourth quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider's stock worth $61,000 after buying an additional 428 shares during the last quarter. NBC Securities Inc. boosted its holdings in Maximus by 114,900.0% during the first quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock worth $78,000 after buying an additional 1,149 shares during the last quarter. Finally, Blue Trust Inc. boosted its holdings in Maximus by 32.8% during the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock worth $84,000 after buying an additional 303 shares during the last quarter. Institutional investors own 97.21% of the company's stock.
Analyst Ratings Changes
Separately, Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.
View Our Latest Stock Analysis on MMS
Maximus Stock Down 3.4%
Shares of NYSE MMS traded down $2.46 during mid-day trading on Tuesday, reaching $69.91. 553,855 shares of the company's stock were exchanged, compared to its average volume of 573,494. The firm has a market capitalization of $3.94 billion, a price-to-earnings ratio of 13.90 and a beta of 0.61. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.87. The business has a fifty day simple moving average of $71.84 and a 200 day simple moving average of $70.89. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97.
Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. The company had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a return on equity of 23.37% and a net margin of 5.56%. Maximus's revenue was up 1.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.57 earnings per share. As a group, equities analysts expect that Maximus, Inc. will post 6.15 EPS for the current fiscal year.
Maximus Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Sunday, August 31st. Shareholders of record on Friday, August 15th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.72%. The ex-dividend date is Friday, August 15th. Maximus's payout ratio is 23.86%.
Insider Buying and Selling
In other Maximus news, Director Gayathri Rajan sold 7,913 shares of the business's stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $72.38, for a total value of $572,742.94. Following the sale, the director owned 14,205 shares in the company, valued at approximately $1,028,157.90. The trade was a 35.78% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.60% of the company's stock.
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Recommended Stories

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.